A surge in first-quarter 2019 investments in Medical Alley Association member startups pushed them past their performance in the same quarter last year, according to the Minnesota-based trade group. Seven of the 10 largest raises of the quarter went to medical device companies, which propelled the sector to its best first quarter on record, nearly doubling the […]
Monteris Medical raises nearly $11M
Monteris Medical (Plymouth, Minn.) has brought in nearly $11 million from its latest investment round as it expands sales and marketing of its NeuroBlate robot-assisted brain surgery device, according to a new Form D filed with the U.S. Securities and Exchange Commission. Monteris had sought roughly $17 million in total from the money-raise. The company has overcome challenges […]
Monteris Medical had a serious recall: Here’s what their CEO did
Soon after Marty Emerson took over as CEO of Monteris Medical, he and other company officials realized that the company’s robot-assisted brain surgery device had a serious overheating problem. Here’s how he led the company through the crisis. Marty Emerson became CEO of Monteris Medical (Plymouth, Minn.) in July 2016. Within a month, the first […]
Monteris Medical expands access to NeuroBlate System with Anthem win
On the heels of a coverage update from health insurance giant Aetna, Monteris Medical has achieved a similar win from Anthem when it comes to epilepsy patients gaining access to Monteris’ NeuroBlate system. Anthem’s clinical utilization management guidelines for laser interstitial thermotherapy, which Monteris announced today, allows Anthem beneficiaries with refractory epilepsy to access the minimally invasive […]
Monteris Medical scores reimbursement win with Aetna
More epilepsy patients could have access to procedures involving Monteris Medical’s NeuroBlate system after a new coverage update from health insurance giant Aetna. The coverage update, which Monteris Medical announced today, involves Aetna’s medical policy for laser interstitial thermotherapy (LITT). It provides coverage for Aetna beneficiaries with refractory epilepsy who have met the established medical necessity criteria […]
Monteris wins FDA nod for NeuroBlate Optic laser probe
Monteris Medical said today it won FDA clearance for the NeuroBlate Optic laser probe designed for its minimally invasive magnetic resonance imaging-guided NeuroBlate robotic laser thermotherapy system, which is intended for use in treating brain tumors and epileptic foci. The Plymouth, Minn.-based company said that the newly cleared laser probe replaces previous generation’s metal thermocouple inside […]
FDA pulls select Monteris Medical NeuroBlate systems in Class I recall
The FDA today issued a recall for select Monteris Medical NeuroBlate systems and laser delivery probes over issues with unexpected MRI-related heating and damage to the tip of the probe that could cause serious injuries. The federal watchdog labeled the recall as a Class I, its most serious class of recall, which indicates the potential […]
Monteris Medical raises $27m Series C for NeuroBlate brain surgery device
Monteris Medical said yesterday that it raised a Series C round worth nearly $27 million it plans to use on R&D, clinical trials and expanding the commercial footprint of its NeuroBlate brain surgery device. Versant Ventures and SightLine Partners led the round, joined by prior backers Birchview Capital and BDC Capital’s Healthcare Venture Fund, Monteris said. The MRI-guided […]
Monteris Medical raises $7m for NeuroBlate
Monteris Medical raised nearly $7 million of a hoped-for $10 million debt-and-options round for the NeuroBlate neurosurgery device it’s developing. Plymouth, Minn.-based Monteris last month won FDA approval for an investigational device exemption trial of NeuroBlate in patients newly diagnosed with a form of brain cancer called glioblastoma multiforme. The MRI-guided device is designed to ablate, necrotize or coagulate […]
Monteris Medical wins FDA IDE nod for another NeuroBlate brain cancer trial
Monteris Medical said today it won FDA investigational device exemption to explore the use of its NeuroBlate system in patients newly diagnosed with glioblastoma multiforme. The NeuroBlate system is designed to ablate, necrotize or coagulate soft tissue during neurosurgery procedures through laser thermotherapy, and is not intended for any specific disease or lesion type, the company […]
Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016
Schellhorn out, Emerson in as Monteris CEO Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year. Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year […]
